Jasbir Seehra, CHIEF EXECUTIVE OFFICER at Keros Therapeutics, Inc. (KROS), sold 7,015 shares at $16.17 ($113K) on 2026-02-19, disclosed to the SEC on 2026-02-20.
Open-market sale of $113k KROS by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.